These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18314782)

  • 21. Massive necrotizing pneumonia with pulmonary gangrene.
    Chen CH; Huang WC; Chen TY; Hung TT; Liu HC; Chen CH
    Ann Thorac Surg; 2009 Jan; 87(1):310-1. PubMed ID: 19101324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe acute bronchitis].
    Gillissen A
    MMW Fortschr Med; 2009 Aug; 151(34-35):49-50. PubMed ID: 19771793
    [No Abstract]   [Full Text] [Related]  

  • 23. Predicting pneumonia in adults with respiratory illness.
    Ebell MH
    Am Fam Physician; 2007 Aug; 76(4):560-2. PubMed ID: 17853631
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current approaches to managing patients with extra-hospital pneumonia in military collectives].
    Guchev IA; Sinopal'nikov AI; Ul'ianov VA; Klochkov OI
    Voen Med Zh; 2001 Nov; 322(11):29-35. PubMed ID: 11871057
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical management of community-acquired pneumonia in adults].
    Pachón J; Alcántara Bellón Jde D; Cordero Matía E; Camacho Espejo A; Lama Herrera C; Rivero Román A; ;
    Med Clin (Barc); 2009 Jun; 133(2):63-73. PubMed ID: 19426999
    [No Abstract]   [Full Text] [Related]  

  • 26. [About the results of using vaccine "Pneumo-23" in Northern fleet].
    Rybachenko VV; Sementsov VK; Manuĭlov VM; Zabolotnyĭ SP
    Voen Med Zh; 2009 Feb; 330(2):11-3, 96. PubMed ID: 19351018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe community acquired pneumonia associated with a desquamating rash due to group A beta-haemolytic streptococcus.
    Hamour A; Bonnington A; Wilkins EG
    J Infect; 1994 Jul; 29(1):77-81. PubMed ID: 7963639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management in the emergency room of patients requiring hospital treatment of community-acquired pneumonia.
    Martínez D; Alvarez Rodríguez V; Ortiz de Zárate MM; Rivas M; Giménez MJ; Aguilar L; Ruiz Polaina MJ; Barberán J; Prieto J;
    Rev Esp Quimioter; 2009 Mar; 22(1):4-9. PubMed ID: 19308740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-acquired pneumonia: treatment at home or in the hospital?
    Aujesky D; Fine MJ
    Am J Med; 2008 Dec; 121(12):1038-40. PubMed ID: 19028194
    [No Abstract]   [Full Text] [Related]  

  • 30. [Peculiarities of the course of the repeated outhospital pneumonia by compulsory-duty servicemen].
    Lebedeva MN; Grishchenko AV
    Voen Med Zh; 2009 Jul; 330(7):24-8. PubMed ID: 19827664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].
    Starodubtseva OI; Vakhrushev IaM
    Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community-acquired pneumonia due to Acinetobacter lwoffii in a patient infected with the human immunodeficiency virus.
    Domingo P; Muñoz R; Frontera G; Pericas R; Martinez E
    Clin Infect Dis; 1995 Jan; 20(1):205-6. PubMed ID: 7727663
    [No Abstract]   [Full Text] [Related]  

  • 33. Community-acquired pneumonia.
    Torres A
    Semin Respir Crit Care Med; 2009 Apr; 30(2):125-6. PubMed ID: 19296411
    [No Abstract]   [Full Text] [Related]  

  • 34. A 44-year-old man with cavitary pneumonia and shock.
    Shaulov A; Benenson S; Cahan A; Hiller N; Korem M
    Neth J Med; 2011 Sep; 69(9):402, 406. PubMed ID: 21978987
    [No Abstract]   [Full Text] [Related]  

  • 35. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community acquired pneumonia. CME Infectious diseases--II.
    Jolobe OM
    J R Coll Physicians Lond; 1998; 32(5):491-2. PubMed ID: 9819750
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical end points of therapy for patients with mild community-acquired pneumonia.
    Gilbert DN
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S140-4. PubMed ID: 18986280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of community acquired pneumonia].
    Drömann D; Schaaf B
    Pneumologie; 2008 Jul; 62(7):411-9; quiz 420-2. PubMed ID: 18609462
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
    Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative assessment of efficacy of the 3d generation cephalosporins, ceftriabol, and claforan, in patients with community-acquired pneumonia].
    Vakhrushev IaM; Starodubtseva OI
    Klin Med (Mosk); 2009; 87(7):53-5. PubMed ID: 19705794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.